{
  "ticker": "JNJ",
  "target_date": "2025-10-01",
  "actual_date": "2025-10-01",
  "collected_at": "2025-12-08T12:21:02.946715",
  "price": {
    "open": 184.83,
    "high": 185.38,
    "low": 182.75,
    "close": 184.87619018554688,
    "volume": 13063800,
    "change_1d_pct": 0.34,
    "change_7d_pct": 6.8,
    "change_30d_pct": 5.41
  },
  "technicals": {
    "rsi_14": 67.42,
    "sma_20": 177.08,
    "sma_50": 173.61,
    "macd": 2.278,
    "macd_signal": 1.563,
    "macd_histogram": 0.715,
    "bb_upper": 183.22,
    "bb_lower": 170.93,
    "price_vs_sma20_pct": 4.4,
    "price_vs_sma50_pct": 6.49,
    "volume_ratio": 1.47
  },
  "fundamentals": {
    "market_cap": 488099086336,
    "pe_ratio": 19.55502,
    "forward_pe": 19.112263,
    "price_to_book": 6.148967,
    "price_to_sales": 5.2968464,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.51,
    "pct_from_52w_low": 44.01
  },
  "macro": {
    "spy": {
      "price": 668.45,
      "change_1d_pct": 0.34,
      "change_7d_pct": 0.79
    },
    "vix": {
      "level": 16.29,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.11
    },
    "dollar_index": {
      "level": 97.71
    },
    "gold": {
      "price": 3867.5
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Nanobiotix Says Early Trial Results Support JNJ-1900 With Chemoradiation in Esophageal Cancer",
      "source": "Yahoo",
      "datetime": 1759353328,
      "summary": "Nanobiotix (NBTX) reported early results from the first two cohorts of a phase 1 trial testing its r",
      "url": "https://finnhub.io/api/news?id=899c9264427b6379f58f59c41065f9af9fe063396d56010cfab98ba5feb1a9d4"
    },
    {
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "source": "Yahoo",
      "datetime": 1759352100,
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fish",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    },
    {
      "headline": "Marla Beck Steps Down as CEO of Hydrafacial Owner",
      "source": "Yahoo",
      "datetime": 1759331485,
      "summary": "Beck will be succeeded as president and CEO of BeautyHealth by Pedro Malha.",
      "url": "https://finnhub.io/api/news?id=0f7c502ea0d4a35f1e71111300da45447cb3edf22b709053c37dc9ce9162c6d6"
    },
    {
      "headline": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End",
      "source": "Yahoo",
      "datetime": 1759331400,
      "summary": "FEATURE  Healthcare stocks have found a second wind, with momentum building across biotech and pharmaceuticals.  The cleared the very round $100 level for the first time in 10 months yesterday. The more pharma-specific surged 3.",
      "url": "https://finnhub.io/api/news?id=fcaea91725db69ea6ff5513a4aa5f0b3ea2968ca11f38eac9e1d0fc75987a454"
    },
    {
      "headline": "ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?",
      "source": "Yahoo",
      "datetime": 1759327980,
      "summary": "Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.",
      "url": "https://finnhub.io/api/news?id=5dd059186ecfe3336a2a03df6d9643c660d0142929799e7b9e6c6a8ee50b044c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}